TY  - JOUR

T1  - Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

JO  - Annals of Oncology

UR  - https://doi.org/10.1093/annonc/mdz239.034

PY  - 2019/10/01

AU  - Rutella S

AU  - Church SE

AU  - Vadakekolathu J

AU  - Reeder S

AU  - Sullivan AH

AU  - Warren S

AU  - Baughman J

AU  - Muth J

AU  - Park H

AU  - Uronis H

AU  - Kang Y-K et al

ED  - 

DO  - DOI: 10.1093/annonc/mdz239.034

PB  - Elsevier BV

VL  - 30

SP  - v38

EP  - v39

Y2  - 2026/02/25

ER  -